Isomorphic labs

A subsidiary of Alphabet Inc., this company focuses on utilizing artificial intelligence to expedite drug discovery and development. It leverages AI technologies to model biological processes, aiming to enhance the efficiency and accuracy of pharmaceutical research. The primary beneficiaries of its innovations are pharmaceutical companies and researchers seeking advanced solutions in drug development.